Agency: Drug Enforcement Administration

Advanced Search

Years: 2000200120022003200420052006200720082009

Pages: 12345>»

[FR Doc 03-31218] 1.Larry E. Davenport, M.D.: Denial of Application for DEA Registration

I. Background

On September 21, 2001, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA) issued an Order to Show Cause (OTSC) to Larry E. Davenport, M.D., (Respondent), proposing to deny his application for a DEA Certificate of
Registration. The basis for the Order to Show Cause was that

Published: 2003-12-18 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-31219] 2.OTC Distribution Company; Revocation of Registration

On May 9, 2000, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to OTC Distribution Company (``OTC'') as to why the OTC's DEA Certificate of Registration as a distributor of List I chemical products should not be revoked as being inconsistent with the public

Published: 2003-12-18 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

[FR Doc 03-30834] 3. Controlled Substances: Established Initial Aggregate Production Quotas for

This notice establishes initial 2004 aggregate production quotas for controlled substances in Schedules I and II of the Controlled Substances Act (CSA).

Published: 2003-12-15 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29964] 4. Importation of Controlled Substances; Notice of Application

Pursuant to Section 1008 of the Controlled Substances Import and Export Act (21 U.S.C. 958(1)), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule II and prior to issuing a registration under Section 1002(a) authorizing the importation of such a substance,

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29976] 5. Manufacturer of Controlled Substances; Notice of Registration

By Notice dated August 19, 2003, and published in the Federal Register on September 2, 2003, (68 FR 52224), American Radiolabeled Chemical, Inc., 11624 Bowling Green Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration for registration as a bulk manufacturer of the basic classes of controlled

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29974] 6. Manufacturer of Controlled Substances; Notice of Registration

By Notice dated August 19, 2003, and published in the Federal Register on September 2, 2003, (68 FR 52224), Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by letter to the Drug Enforcement Administration for registration as a bulk manufacturer of Dextropropoxyphene (9273), a basic class of Schedule II

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29971] 7. Importer of Controlled Substances; Notice of Registration

By Notice dated June 25, 2003 and published in the Federal Register on July 14, 2003, (68 FR 41661), Cambrex North Brunswick, Inc., Technology Center of New Jersey, 661 Highway One, North Brunswick, New Jersey 08902, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Phenylacetone

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29972] 8. Manufacturer of Controlled Substances; Notice of Registration

By Notice dated June 25, 2003, and published in the Federal Register on July 14, 2003, (68 FR 41661), Cambrex North Brunswick, Inc., Technology Centre of New Jersey, 661 Highway One, North Brunswick, New Jersey 08902, made application by renewal to the Drug Enforcement Administration for registration as a bulk manufacturer of the basic classes

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

[FR Doc 03-29977] 9. Manufacturer of Controlled Substances; Notice of Registration

By Notice dated August 19, 2003, and published in the Federal Register on September 2, 2003, (68 FR 52224), Cambridge Isotope Laboratories, Inc., 50 Frontage Road, Andover, Massachusetts 01810, made application by renewal to the Drug Enforcement Administration for registration as a bulk manufacturer of the basic classes of controlled

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29966] 10. Anthony D. Dinozzi, D.D.S., Revocation of Registration

On September 25, 2002, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Anthony David Dinozzi, D.D.S. (Respondent) notifying him of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of Registration, BD4361692 under 21 U.S.C.

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29961] 11. Manufacturer of Controlled Substances; Notice of Application

Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on April 25,
[[Page 67476]]
2003, Lifepoint, Inc., 10400 Trademark Street, Rancho Cucamonga, California 91730, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29975] 12. Manufacturer of Controlled Substances; Notice of Registration

By Notice dated August 19, 2003, and published in the Federal Register on September 2, 2003, (68 FR 52225), LinZhi International, Inc., 687 North Pastoria Avenue, Sunnyvale, California 94085, made application to the Drug Enforcement Administration for registration as a bulk manufacturer of the basic classes of controlled substances listed

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29967] 13. Jules M. Lusman, M.D., Revocation of Registration

On September 6, 2002, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Jules Lusman, M.D. (Respondent) notifying him of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of Registration, BL2210300 under 21 U.S.C. 824(a)(3) and

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29962] 14. Manufacturer of Controlled Substances; Notice of Application

Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 11, 2003 and September 18, 2003, National Center for Development of Natural Products, The University of Mississippi, 135 Coy Waller Lab Complex, University, Mississippi 38677, made application by renewal to the Drug Enforcement

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29968] 15. Importer of Controlled Substances; Notice of Registration

By Notice dated July 2, 2003 and published in the Federal Register on July 21, 2003, (68 FR 431650, Noramco Inc., 500 Old Swedes Landing Road, Wilmington, Delaware 19801, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed below:] [[Page

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29973] 16. Manufacturer of Controlled Substances; Notice of Registration

By Notice dated June 25, 2003, and published in the Federal Register on July 14, 2003, (68 FR 41663), Novus Fine Chemicals, LLC, 611 Broad Street, Carlstadt, New Jersey 07072, made application by renewal to the Drug Enforcement Administration for registration as a bulk manufacturer of the basic class of Methylphenidate (1724), a Schedule II

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29969] 17. Manufacturer of Controlled Substances; Notice of Registration

By Notice dated July 22, 2003, and published in the Federal Register on August 5, 2003, (68 FR 46226), Penick, Corporation, 158 Mount Olivet Avenue, Newark, New Jersey 07114, made application by renewal to the Drug Enforcement Administration for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29965] 18. Keith Perry, M.D. Revocation of Registration

On October 17, 2002, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration (DEA), issued an Order to Show Cause to Keith O'Neil Perry, M.D. (Respondent) notifying him of an opportunity to show cause as to why DEA should not revoke his DEA Certificate of Registration, AP3109077 under 21 U.S.C. 824(a)(3)

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29963] 19. Manufacturer of Controlled Substances; Notice of Application

Pursuant to section 1301.33(a) of title 21 of the Code of Federal Regulations (CFR), this is notice that on September 18, 2003, Sigma Aldrich Research Biochemicals, Inc., 13 Strathmore Road, Natick, Massachusetts 01760, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29960] 20. Importation of Controlled Substances; Notice of Application

Pursuant to Section 1008 of the Controlled Substances Import and Export Act (21 U.S.C. 958(1)), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule II and prior to issuing a regulation under Section 1002(a) authorizing the importation of such a substance,

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29970] 21. Manufacturer of Controlled Substances, Notice of Registration

By Notice dated July 22, 2003, and published in the Federal Register on August 5, 2003, (68 FR 46227), Wildlife Laboratories, Inc., 1401 Duff Drive, Suite 600, Fort Collins, Colorado 80524, made application by renewal to the Drug Enforcement Administration for registration as a bulk manufacturer of Carfentanil (9743), a basic class of

Published: 2003-12-02 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29236] 22. Chemical Registration Waivers; Exemption From Chemical Registration Fees for

DEA is proposing amending its regulations to waive the requirement of registration for contract processors, medical/first aid kit providers, distributors of sample packages of drug products, and distributors of research/reference standards pursuant to 21 U.S.C. 822(d). These actions are being taken in response to industry comments and suggestions.

Published: 2003-11-25 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-29336] 23. Recordkeeping and Reporting Requirements for Drug Products Containing

DEA proposes to amend its regulations to require additional recordkeeping and reporting requirements for drug products containing gammahydroxybutyric acid (GHB) for which an application has been approved under the Federal Food, Drug, and Cosmetic Act. DEA proposes [[Page 66049]]
these changes pursuant to section 4 of the ``Hillory J. Farias and

Published: 2003-11-25 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-27889] 24. Sale by Federal Departments or Agencies of Chemicals Which Could Be Used in

The Drug Enforcement Administration is finalizing the Notice of Proposed Rulemaking (NPRM) published in the Federal Register on May 8, 2003 (68 FR 24689). That NPRM proposed to conform DEA regulations to provisions of the National Defense Authorization Act which provides that a Federal department or agency may not sell from its stocks any chemical

Published: 2003-11-06 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

[FR Doc 03-27636] 25. Controlled Substances: Proposed Aggregate Production Quotas for 2004

This notice proposes initial year 2004 aggregate production quotas for controlled substances in Schedules I and II of the Controlled Substances Act (CSA).

Published: 2003-11-04 DEPARTMENT OF JUSTICE : Drug Enforcement Administration

 

Years: 2000200120022003200420052006200720082009

Pages: 12345>»